PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Infectious Diseases, Microbiology and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain.\', \'Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Unit of Infectious Diseases and Microbiology, University Hospital Virgen Macarena, Seville, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.\', \'CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Unit of Infectious Diseases, Service of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain.\', \'Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain; Service of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.\', \'CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Service of Infectious Diseases, Hospital Universitario de Bellvitge, Barcelona, Spain; Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.\', \'CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.\', \'Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; Service of Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.\', \'Fundación SEIMC/GeSIDA, Madrid, Spain.\', \'Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Unit of Infectious Diseases and Microbiology, University Hospital Virgen Macarena, Seville, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Department of Medicine, Universidad de Sevilla, Seville, Spain. Electronic address: jesusrb@us.es.\', \'Unit of Infectious Diseases, Microbiology and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Department of Medicine, Universidad de Sevilla, Seville, Spain. Electronic address: pachon@us.es.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(21)01359-710.1016/j.biopha.2021.112572
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 34954640
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34954640>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34954640>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all